Citius OncologyCTOR
13F holders, Q2 2025 (June 30)7holders +1
2new positions
1sold out
$4.35avg. 13F price*
At the end of Q2 2025, 7 institutions reported holding Citius Oncology Inc. (CTOR) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were Jane Street Group, LLC ($465K), Geode Capital Management, LLC ($249K) and IFP Advisors, Inc ($97K).
- Company
- Citius Oncology Inc.
- CUSIP
- 17331Y109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $516K |
| Exits | 1 | $11K |
All 13F filers, Q1 2025 → Q2 2025: 168,805 shares bought and 46,321 shares sold, net +122,484 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Jane Street Group, LLC | 0.00% | New | 106,970 | $465K |
| Geode Capital Management, LLC | 0.00% | Add +179.0% | 57,297 | $249K |
| IFP Advisors, Inc | 0.00% | No change | 22,215 | $97K |
| UBS Group AG | 0.00% | Reduce -69.0% | 15,423 | $67K |
| Arkadios Wealth Advisors | 0.00% | New | 11,666 | $51K |
| Bank of America Corp. | 0.00% | Add +5256.9% | 8,571 | $37K |
| Osaic Holdings, Inc. | 0.00% | Add +1428.6% | 5,350 | $23K |
"% of holder's portfolio" is CTOR's weight in each manager's 13F, not the share of Citius Oncology Inc. the manager owns.